"Pediatric Eosinophilic Esophagitis: A 10-Year Experience At a Canadian Tertiary Care Centre"
Jason A. Ohayon, MD, Perri R. Tutelman, Jefferson Terry, MD, PhD, Mary E. Sherlock, MB BCh, BAO, PhDhttps://aaaai.confex.com/aaaai/2014/webprogram/Paper11128.html
Approximately half of the patients treated with corticosteroids reported symptomatic improvement while over three-quarters of patients reported an improvement on allergy avoidance dietary therapy. At a median follow-up of 31.1 (IQR=81.8-13.4) months, 16 (17%) patients had no change in symptoms from diagnosis, 53 (56%) patients continued to experience symptoms but at a decreased severity, and 17 (18%) experienced a complete resolution of symptoms. Eight (9%) of patients were lost to follow up.